This, together with the frequent expression on melanoma cells of ligands recognized by major activating NK receptors (including MICA/B, ULBPs, PVR, Nectin-2 and B7H6) [34–36, 47], suggests that NK cells may indeed represent important effectors against this tumor. The gene discussed is NCR3LG1; the disease is neoplasm.